Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap
F Daneshnia, JN de Almeida Júnior, M Ilkit… - The Lancet …, 2023 - thelancet.com
Candida parapsilosis is one of the most commen causes of life-threatening candidaemia,
particularly in premature neonates, individuals with cancer of the haematopoietic system …
particularly in premature neonates, individuals with cancer of the haematopoietic system …
COVID-19-associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions?
The recent global pandemic of COVID-19 has predisposed a relatively high number of
patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing …
patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing …
Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections
Breakthrough fungal infections in patients on antimicrobial prophylaxis during allogeneic
hematopoietic cell transplantation (allo-HCT) represent a major and often unexplained …
hematopoietic cell transplantation (allo-HCT) represent a major and often unexplained …
The quiet and underappreciated rise of drug-resistant invasive fungal pathogens
A Arastehfar, C Lass-Flörl, R Garcia-Rubio… - Journal of Fungi, 2020 - mdpi.com
Human fungal pathogens are attributable to a significant economic burden and mortality
worldwide. Antifungal treatments, although limited in number, play a pivotal role in …
worldwide. Antifungal treatments, although limited in number, play a pivotal role in …
Candidemia: evolution of drug resistance and novel therapeutic approaches
AM Tortorano, A Prigitano, G Morroni… - Infection and Drug …, 2021 - Taylor & Francis
Candidemia and invasive candidiasis are the most common healthcare-associated invasive
fungal infections, with a crude mortality rate of 25–50%. Candida albicans remains the most …
fungal infections, with a crude mortality rate of 25–50%. Candida albicans remains the most …
[HTML][HTML] The changing epidemiology of fungal infections
C Lass-Flörl, S Steixner - Molecular Aspects of Medicine, 2023 - Elsevier
Invasive fungal diseases are common complications in critically ill patients and in those with
significant underlying imbalanced immune systems. Fungal co-, and/or super-infections are …
significant underlying imbalanced immune systems. Fungal co-, and/or super-infections are …
Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features
L Lv, S Gu, H Jiang, R Yan, Y Chen, Y Chen… - Communications …, 2021 - nature.com
The relationship between gut microbes and COVID-19 or H1N1 infections is not fully
understood. Here, we compared the gut mycobiota of 67 COVID-19 patients, 35 H1N1 …
understood. Here, we compared the gut mycobiota of 67 COVID-19 patients, 35 H1N1 …
Candida parapsilosis complex in the clinical setting
M Govrins, C Lass-Flörl - Nature Reviews Microbiology, 2024 - nature.com
Representatives of the Candida parapsilosis complex are important yeast species causing
human infections, including candidaemia as one of the leading diseases. This complex …
human infections, including candidaemia as one of the leading diseases. This complex …
Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack
Candida species are common colonizers of the human skin, vagina, and the gut. As human
commensals, Candida species do not cause any notable damage in healthy individuals; …
commensals, Candida species do not cause any notable damage in healthy individuals; …
Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
Candida parapsilosis is becoming a predominant non-albicans cause of invasive
candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis …
candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis …